Ying Luo

ORCID: 0000-0003-4945-4209
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Organ Transplantation Techniques and Outcomes
  • Pancreatic and Hepatic Oncology Research
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Gallbladder and Bile Duct Disorders
  • Neuroendocrine Tumor Research Advances
  • MicroRNA in disease regulation
  • Liver Disease and Transplantation
  • Cancer Immunotherapy and Biomarkers
  • Transplantation: Methods and Outcomes
  • Pediatric Hepatobiliary Diseases and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiovascular Health and Disease Prevention
  • Cancer-related molecular mechanisms research
  • Cancer Diagnosis and Treatment
  • Pancreatitis Pathology and Treatment
  • Circular RNAs in diseases
  • Liver Disease Diagnosis and Treatment
  • MRI in cancer diagnosis
  • Neuroblastoma Research and Treatments
  • Cleft Lip and Palate Research
  • Esophageal and GI Pathology
  • Head and Neck Cancer Studies
  • Cardiac Imaging and Diagnostics
  • Renal Transplantation Outcomes and Treatments

Guangzhou Medical University
2021-2025

First Affiliated Hospital of Guangzhou Medical University
2025

China Aerospace Science and Industry Corporation (China)
2019-2024

The University of Texas Southwestern Medical Center
2024

Southwestern Medical Center
2024

Chinese PLA General Hospital
2012-2024

Southwestern University
2024

Hunan Cancer Hospital
2004-2024

Stomatology Hospital
2014-2022

Chiang Mai University
2022

Abstract Growing evidence demonstrated that cell death pathways including ferroptosis, apoptosis and necroptosis contribute to cardiac ischaemia/reperfusion (I/R) injury. We hypothesized differently myocardial damage during acute I/R Rats underwent or sham operation. I/R‐operated rats were divided into 4 groups: vehicle, (Z‐vad), ferroptosis (Fer‐1) (Nec‐1) inhibition. in each inhibitor group subdivided 3 different dose regimens: low, medium high. Infarct size, left ventricular (LV)...

10.1111/jcmm.17275 article EN cc-by Journal of Cellular and Molecular Medicine 2022-03-21

Liver cancer primarily accounts for the majority of malignancies liver. MicroRNAs (miRNAs) are endogenous non-coding RNAs, which important in tumorigenesis. Abnormal expression microRNA-346 (miR-346) has been demonstrated various types human cancer, however, its and potential molecular mechanism liver remains to be elucidated. Expression levels miR-346 cell lines were determined by quantitative polymerase chain reaction. The effect on proliferation was evaluated an MTT assay; migration...

10.3892/ol.2017.6561 article EN Oncology Letters 2017-07-08

Abstract High‐resolution MRI provides unique information about morphology of atherosclerotic carotid plaque. In this study, the accuracy and precision measurements plaque burden lumen narrowing were determined for in vivo black blood assessment with respect to ex a group 37 atherosclerosis patients who underwent endarterectomy (CEA). Three different measures compared between paired MR images: maximum wall area (MWA), minimum (mLA), volume (WV). MWA WV are burden, while mLA is measure...

10.1002/mrm.10503 article EN Magnetic Resonance in Medicine 2003-06-13

Recent studies have uncovered the vital roles played by microRNAs in regulating cardiac injury. Among them, enriched microRNA-1 (miR-1) has been extensively studied and proven to be detrimental myocytes. Hence, current study aimed explore whether miR-1 affects myocardial ischemia-reperfusion injury (MIRI) rats undergoing sevoflurane preconditioning underlying mechanism. After successful model establishment, with MIRI were transfected mimics or inhibitors of miR-1, siRNA against MAPK3, then...

10.1152/ajpcell.00310.2017 article EN AJP Cell Physiology 2018-05-09

PURPOSE: To investigate whether postcontrast three-dimensional (3D) magnetic resonance (MR) imaging would yield more accurate measurement of carotid artery wall volume and maximum area, which are both measures plaque burden, than precontrast 3D MR imaging. MATERIALS AND METHODS: Eleven consecutive patients scheduled to undergo endarterectomy were recruited for the study. A fast gradient-recalled-echo sequence was applied acquire images wall. The same used image ex vivo excised as a reference...

10.1148/radiol.2281020484 article EN Radiology 2003-07-01

Pancreatic cancer is the fourth leading cause of cancer‑associated deaths in Western countries, and ranks sixth among diseases, with highest mortality rate China. Deregulation micro (miR) RNA may contribute to occurrence progression numerous cancers, including pancreatic cancer. In particular, deregulation microRNA‑720 (miR‑720) has been reported various types human However, expression biological role miR‑720 remains be elucidated. The present study aimed investigate functional determine...

10.3892/mmr.2017.7732 article EN Molecular Medicine Reports 2017-10-05

Background Choledochal cyst excision and biliary enteric reconstruction constitute the best therapy for choledochal cyst. And laparoscopy is currently used to cure this disease now. Methods We retrospectively analyzed clinical data of 34 cases total laparoscopic between January 2007 August 2011. All patients underwent in vitro Roux-en-Y hepatoenterostomy. Results successful excision. The operation time was 200-360 minutes. duration hospital stay 3-7 days. Follow-up observations lasted 1-56...

10.3760/cma.j.issn.0366-6999.20111678 article EN cc-by-nc-nd Chinese Medical Journal 2013-03-05

Spleen-preserving laparoscopic distal pancreatectomy is technically challenging. New surgical robotic systems are now available and show promising outcomes but were very recently implemented in China. Seven patients underwent using the da Vinci Robotic System (RDP) for benign or borderline malignant pancreatic tumors. Spleen preservation rate, blood loss, operative complications assessed. Mean age was 44.6 ± 13.7 years. Surgery uneventful all patients, without conversion to laparotomy. The...

10.1186/s12957-015-0671-x article EN cc-by World Journal of Surgical Oncology 2015-09-16
Coming Soon ...